Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...

The final milestone in the current roadmap is D19, projected for 2028. This device will incorporate three additional blood ...

Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479), a ...

Health First cardiologist Dr. Kevin Campbell, M.D., FACC, MBA, CPE, and Fleet Surgeon for the Eau Gallie Yacht Club, knows a steady rhythm matters ...

Doctors at Northwestern Memorial Hospital are the first in Illinois to offer a new treatment for atrial fibrillation, a heart ...

Investigators led by LMU University Hospital report a higher-than-expected one-year incidence of new-onset atrial ...

Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will be exclusively available through ...

MOBILE APP. A SERIOUS HEART CONDITION CAN CHANGE THE COURSE OF OUR LIVES JUST IN A MATTER OF MOMENTS. AND SEPTEMBER IS NATIONAL ATRIAL FIBRILLATION, OR AFIB AWARENESS MONTH. SO YOU SEE, I HAVE A WHOLE ...

Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a pharmaceutical company ...

President Trump has sparked controversy by suggesting pregnant individuals limit Tylenol use due to an unsubstantiated link to autism and advocating for delayed infant vaccination schedules, ...

Data from implantable monitors show a low AF burden with time, leading some to question the need for oral anticoagulation.